📰 Developing News
Page 91 - Developing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Developing. Real-time updates on events, politics, business and more.
June 6, 2023
SOUTH SAN FRANCISCO, Calif., June 06, 2023 -- Day One Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people... | June 6, 2023
June 5, 2023
The United States House of Representatives recently approved "the PRC Is Not A Developing Country Act".The unanimous decision requires the US Department of State to change China's status as a "developing country" in international organizations where the United States participates in or is a part of, and to modify its status to "developed country".
June 5, 2023
Cyclo Therapeutics, Inc. , a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today... | June 5, 2023
June 5, 2023
Precision BioSciences, Inc. a clinical stage gene editing company developing ARCUS®-based in vivo gene editing and ex vivo allogeneic CAR T therapies, today announced that members of management... | June 5, 2023
June 5, 2023
BOSTON, June 05, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T... | June 5, 2023
June 5, 2023
SAN CARLOS, Calif., June 05, 2023 -- Allakos Inc. , a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved... | June 5, 2023
June 5, 2023
FLORHAM PARK, N.J., June 05, 2023 -- PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious... | June 5, 2023
June 5, 2023
Astria Therapeutics, Inc. , a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and... | June 5, 2023
June 5, 2023
WESTLAKE VILLAGE, Calif., June 05, 2023 -- Arcutis Biotherapeutics, Inc. , an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in... | June 5, 2023
June 5, 2023
Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of... | June 5, 2023